Lyell Immunopharma (LYEL) News Today $1.64 +0.01 (+0.61%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 13, 2024 | marketbeat.comLyell Immunopharma, Inc. (NASDAQ:LYEL) Sees Large Drop in Short InterestLyell Immunopharma, Inc. (NASDAQ:LYEL - Get Free Report) was the target of a large decrease in short interest in the month of June. As of June 30th, there was short interest totalling 17,920,000 shares, a decrease of 25.8% from the June 15th total of 24,150,000 shares. Based on an average daily trading volume, of 1,060,000 shares, the short-interest ratio is presently 16.9 days. Approximately 15.1% of the company's shares are sold short.July 2, 2024 | marketbeat.comLyell Immunopharma, Inc. (NASDAQ:LYEL) Short Interest Up 19.6% in JuneLyell Immunopharma, Inc. (NASDAQ:LYEL - Get Free Report) was the target of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 24,150,000 shares, an increase of 19.6% from the May 31st total of 20,200,000 shares. Approximately 20.4% of the shares of the stock are short sold. Based on an average daily volume of 788,600 shares, the short-interest ratio is presently 30.6 days.June 27, 2024 | marketbeat.comBank of America Lowers Lyell Immunopharma (NASDAQ:LYEL) Price Target to $6.00Bank of America reduced their price objective on shares of Lyell Immunopharma from $9.00 to $6.00 and set a "buy" rating for the company in a research note on Thursday.June 27, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Receives "Neutral" Rating from HC WainwrightHC Wainwright reissued a "neutral" rating and set a $1.00 price objective (down from $6.00) on shares of Lyell Immunopharma in a report on Thursday.June 26, 2024 | globenewswire.comLyell Immunopharma Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797, a ROR1-targeted CAR-T Cell Product Candidate Enhanced with its Proprietary Anti-exhaustion TechnologyJune 21, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Shares Gap Up to $2.08Lyell Immunopharma (NASDAQ:LYEL) Shares Gap Up to $2.08June 14, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Stock Price Down 8.9%Lyell Immunopharma (NASDAQ:LYEL) Stock Price Down 8.9%June 13, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Sees Unusually-High Trading VolumeLyell Immunopharma (NASDAQ:LYEL) Sees Large Volume IncreaseJune 11, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Stock Price Up 3.4%Lyell Immunopharma (NASDAQ:LYEL) Trading Up 3.4%June 11, 2024 | marketbeat.comInvenomic Capital Management LP Takes $1.45 Million Position in Lyell Immunopharma, Inc. (NASDAQ:LYEL)Invenomic Capital Management LP acquired a new stake in shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 746,415 shares of thJune 10, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Shares Gap Down to $2.43Lyell Immunopharma (NASDAQ:LYEL) Shares Gap Down to $2.43June 6, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Stock Price Down 5.6%Lyell Immunopharma (NASDAQ:LYEL) Stock Price Down 5.6%June 3, 2024 | globenewswire.comLyell Immunopharma to Participate in the Goldman Sachs Global Healthcare ConferenceMay 29, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Trading Down 5.8%Lyell Immunopharma (NASDAQ:LYEL) Stock Price Down 5.8%May 22, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Shares Up 6.1%Lyell Immunopharma (NASDAQ:LYEL) Trading 6.1% HigherMay 20, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Shares Gap Down to $2.74Lyell Immunopharma (NASDAQ:LYEL) Shares Gap Down to $2.74May 16, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Stock Price Up 5.7%Lyell Immunopharma (NASDAQ:LYEL) Trading Up 5.7%May 16, 2024 | marketbeat.comLyell Immunopharma, Inc. (NASDAQ:LYEL) Sees Significant Increase in Short InterestLyell Immunopharma, Inc. (NASDAQ:LYEL - Get Free Report) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 19,970,000 shares, a growth of 9.5% from the April 15th total of 18,230,000 shares. Approximately 16.9% of the company's stock are short sold. Based on an average daily trading volume, of 896,800 shares, the short-interest ratio is currently 22.3 days.May 13, 2024 | markets.businessinsider.comBank of America Securities Keeps Their Buy Rating on Lyell Immunopharma (LYEL)May 8, 2024 | marketbeat.comWuXi AppTec Co. Ltd. Takes Position in Lyell Immunopharma, Inc. (NASDAQ:LYEL)WuXi AppTec Co. Ltd. purchased a new stake in shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 8,180,678 shares of the company's stock, valued at approMay 7, 2024 | globenewswire.comLyell Immunopharma to Participate in BofA Securities Health Care ConferenceMay 7, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Alnylam Pharma (ALNY), Crispr Therapeutics AG (CRSP)May 7, 2024 | finance.yahoo.comLyell Immunopharma First Quarter 2024 Earnings: US$0.24 loss per share (vs US$0.27 loss in 1Q 2023)May 7, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Stock Rating Reaffirmed by HC WainwrightHC Wainwright restated a "buy" rating and issued a $6.00 target price on shares of Lyell Immunopharma in a research note on Tuesday.May 6, 2024 | investorplace.comLYEL Stock Earnings: Lyell Immunopharma Beats EPS for Q1 2024May 6, 2024 | globenewswire.comLyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024April 22, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Trading Up 5.8%Lyell Immunopharma (NASDAQ:LYEL) Trading 5.8% HigherApril 18, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Trading Down 4.6%Lyell Immunopharma (NASDAQ:LYEL) Trading Down 4.6%April 16, 2024 | morningstar.comLyell Immunopharma Inc Ordinary Shares LYELApril 15, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Shares Gap Down to $3.01Lyell Immunopharma (NASDAQ:LYEL) Shares Gap Down to $3.01April 12, 2024 | benzinga.comArgan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On FridayApril 11, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Trading Up 4.9%Lyell Immunopharma (NASDAQ:LYEL) Trading Up 4.9%April 10, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Stock Price Down 7.5%Lyell Immunopharma (NASDAQ:LYEL) Shares Down 7.5%April 4, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Trading 4.9% Higher Lyell Immunopharma (NASDAQ:LYEL) Stock Price Up 4.9%April 4, 2024 | finance.yahoo.comOutpace Bio Announces Multiple Presentations at the 2024 American Association of Cancer Research (AACR) Annual MeetingApril 2, 2024 | seekingalpha.comBiomea Fusion drops as JPMorgan downgrades on data for lead assetMarch 28, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Trading Up 5.9%Lyell Immunopharma (NASDAQ:LYEL) Shares Up 5.9%March 20, 2024 | finance.yahoo.com2seventy bio Announces Appointments of Eli Casdin and Charles Newton to Board of DirectorsMarch 20, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Shares Gap Down to $1.99Lyell Immunopharma (NASDAQ:LYEL) Shares Gap Down to $1.99March 17, 2024 | finance.yahoo.comLyell Immunopharma, Inc.'s (NASDAQ:LYEL) market cap decline of US$89m may not have as much of an impact on institutional owners after a year of 1.4% returnsMarch 13, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Shares Gap Up to $2.18Lyell Immunopharma (NASDAQ:LYEL) Shares Gap Up to $2.18March 11, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Shares Down 6.4% Lyell Immunopharma (NASDAQ:LYEL) Stock Price Down 6.4%March 10, 2024 | finanznachrichten.deLyell Immunopharma, Inc: Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual MeetingMarch 5, 2024 | globenewswire.comLyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual MeetingFebruary 28, 2024 | finance.yahoo.comLyell Immunopharma Inc (LYEL) Reports 2023 Financial Results and Business HighlightsFebruary 28, 2024 | globenewswire.comLyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023February 26, 2024 | globenewswire.comLyell Immunopharma Announces Participation in March Investor ConferencesFebruary 20, 2024 | investing.comLyell Immunopharma Inc (LYEL)January 30, 2024 | benzinga.comLyell Immunopharma Stock (NASDAQ:LYEL) Dividends: History, Yield and DatesJanuary 3, 2024 | finance.yahoo.comLyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference Get Lyell Immunopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LYEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Nvidia insiders dumping shares (Ad)All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can. To see Porter Stansberry's new AI prediction go here now. LYEL Media Mentions By Week LYEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LYEL News Sentiment▼0.940.62▲Average Medical News Sentiment LYEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LYEL Articles This Week▼11▲LYEL Articles Average Week Get Lyell Immunopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LYEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ERAS News ALEC News ADCT News VERV News ALLO News BLUE News TIL News ACHL News BCYC News AKRO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LYEL) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyell Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyell Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
